The family eventually found that medication. Later, two others Abby needed were hard to find. The Brays, like thousands of ...

Hims & Hers Health (NYSE:HIMS) is up ~10% in Monday morning trading following a recent lawsuit challenging the U.S. FDA's ...

If you're over 65 years old, there is a 1 in 4 chance you are navigating a mental health condition, according to the National Council on Aging, and an even higher chance you're enrolled in Medicare.

A Montgomery County mother found 42 drug treatment programs for her son. Here’s what families can face as they seek care.

The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

The rising cost of prescription medications in the U.S. is a serious issue, particularly for those needing life-saving ...

Adding a six-week course of chemotherapy to the standard course of treatment for locally advanced cervical cancer resulted in ...

Madrigal Pharmaceuticals (NASDAQ:MDGL) is a clinical-stage biopharmaceutical company specializing in developing therapies for ...

Akero Therapeutics (NASDAQ:AKRO) is a biotechnology company that is developing a treatment for Metabolic ...

A prescription digital therapeutic for insomnia was associated with significant improvements in sleep, depression, and anxiety.

In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...